Cancer Type: Genitourinary
Study Type: Treatment
Phase: Phase II
Principal Investigator: Sexton, Wade
QUILT-3.032: A Multicenter Clinical Trial of Intravesical Bacillus Calmette-Guerin (BCG) in Combination with ALT-803 in Patients with BCG Unresponsive High Grade Non-Muscle Invasive Bladder Cancer
This is a Phase II, open-label, single-arm, multicenter study of intravesical BCG plus ALT-803 in patients with BCG unresponsive high grade non-muscle invasive bladder cancer (NMIBC). All patients treated in the study will receive via a urinary catheter in the bladder, BCG plus ALT-803 weekly for 6 consecutive weeks (initial induction treatment period). After the first disease assessment, eligible patients will receive either a 3-week maintenance course or a 6-week re-induction course (second treatment period) at Month 3. Eligible patients will continue to receive maintenance treatment in the third treatment period at Months 6, 9, 12, and 18.
Primary: Cohort A: To assess the antitumor activity of intravesical BCG in combination with ALT-803 in patients with BCG unresponsive high-grade NMIBC as determined by complete response rate (for BCG-unresponsive carcinoma in situ (CIS) [with or without Ta/T1 papillary disease]) using cystoscopy, confirmatory bladder biopsy and urine cytology; Cohort B: To determine disease-free rate (for BCG-unresponsive high-grade Ta/T1 papillary disease) using cystoscopy and urine cytology Key Secondary Cohort A: To assess the duration of complete response (for BCG-unresponsive CIS [with or without Ta/T1 papillary disease]); Cohort B: To assess disease-free survival (for BCG-unresponsive high-grade Ta/T1 papillary disease)
Immunotherapy; Therapy (NOS)
ALT-803 (); BCG ()
If you are interested in learning more about clinical trials, our clinical trial navigators can discuss your options and recommend opportunities that may be suitable for you. Call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form.
Back to top
Please call 1-888-663-3488 for support from a Moffitt representative. New Patients and Healthcare Professionals can submit an online form by selecting the appropriate button below. Existing patients can call 1-888-663-3488. Click here for a current list of insurances accepted at Moffitt.
NEW PATIENTS To request a new patient appointment, please fill out the online form or call 1-888-663-3488.
REFERRING PHYSICIANS Providers and medical staff can refer patients by submitting our online referral form.
Moffit now offers Virtual Visits for patients. If you are eligible for a virtual appointment, our scheduling team will discuss this option further with you.
Moffitt Cancer Center is committed to the health and safety of our patients and their families. For more information on how we’re protecting our new and existing patients, visit our COVID-19 Info Hub
A secure website for patients to access their medical care at Moffitt.
An online resource for referring physicians and their staff.
For Moffitt faculty & staff members to access MoffittNet applications.
Our patient services specialists can assist you with scheduling an appointment, questions about medical records, insurance, billing and more.
Patient Appointment Center Hours: 7 a.m. to 7 p.m. Monday - Friday; 8 a.m. to noon Saturday